259 related articles for article (PubMed ID: 18721252)
1. Sublingual immunotherapy: the quest for innovative adjuvants.
Goldman M
Clin Exp Allergy; 2008 Nov; 38(11):1705-6. PubMed ID: 18721252
[No Abstract] [Full Text] [Related]
2. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
[TBL] [Abstract][Full Text] [Related]
3. [Apropos of sublingual specific immunotherapy].
Sabbah A
Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
[No Abstract] [Full Text] [Related]
4. [Specific immunotherapy and therapeutic strategies in allergic diseases. What's new?].
Tonnel AB
Bull Acad Natl Med; 2005 Oct; 189(7):1475-87; discussion 1488-9. PubMed ID: 16669146
[TBL] [Abstract][Full Text] [Related]
5. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
[TBL] [Abstract][Full Text] [Related]
6. Sublingual vaccines based on wild-type recombinant allergens.
Van Overtvelt L; Razafindratsita A; St-Lu N; Didierlaurent A; Batard T; Lombardi V; Martin E; Moingeon P
Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of the hyposensitization effect].
Bachert C
HNO; 1995 May; 43(5):271-2. PubMed ID: 7607909
[No Abstract] [Full Text] [Related]
8. Functional regulatory T cells and allergen immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):559-66. PubMed ID: 20859202
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic T cells, Th1/Th17 cytokines and TLR2/TLR4 expressing dendritic cells predominate the microenvironment within distinct oral mucosal sites.
Allam JP; Duan Y; Winter J; Stojanovski G; Fronhoffs F; Wenghoefer M; Bieber T; Peng WM; Novak N
Allergy; 2011 Apr; 66(4):532-9. PubMed ID: 21087216
[TBL] [Abstract][Full Text] [Related]
10. Different immunotherapy applications--different mechanisms? SLIT versus SCIT--differences in the mode of action.
Allam JP; Bieber T; Novak N
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():237-40; discussion 240-5. PubMed ID: 20799467
[No Abstract] [Full Text] [Related]
11. [Sublingual immunotherapy and Th1 adjuvant immunotherapy].
Okamoto Y
Arerugi; 2008 Jun; 57(6):685-91. PubMed ID: 18591899
[No Abstract] [Full Text] [Related]
12. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?
Lebre MC; Tak PP
Hum Immunol; 2009 May; 70(5):321-4. PubMed ID: 19236901
[TBL] [Abstract][Full Text] [Related]
13. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.
Saint-Lu N; Tourdot S; Razafindratsita A; Mascarell L; Berjont N; Chabre H; Louise A; Van Overtvelt L; Moingeon P
Allergy; 2009 Jul; 64(7):1003-13. PubMed ID: 19220212
[TBL] [Abstract][Full Text] [Related]
14. [Specific immunotherapy. Subcutaneous or sublingual?].
Stiefelhagen P
MMW Fortschr Med; 2008 Jun; 150(24):14, 16. PubMed ID: 18605053
[No Abstract] [Full Text] [Related]
15. Mucosal regulatory T cells in airway hyperresponsiveness.
Strickland D; Wikstrom M; Turner D; Holt P
Chem Immunol Allergy; 2008; 94():40-47. PubMed ID: 18802335
[TBL] [Abstract][Full Text] [Related]
16. Immunologic responses to sublingual allergen immunotherapy.
Akdis M
Clin Allergy Immunol; 2008; 21():71-86. PubMed ID: 18828499
[No Abstract] [Full Text] [Related]
17. Mucosal immunization application to allergic disease: sublingual immunotherapy.
Frati F; Moingeon P; Marcucci F; Puccinelli P; Sensi L; Di Cara G; Incorvaia C
Allergy Asthma Proc; 2007; 28(1):35-9. PubMed ID: 17390755
[TBL] [Abstract][Full Text] [Related]
18. Adjuvants for immunotherapy: lost in translation?
van Hemelen D; van Oosterhout AJ
Clin Exp Allergy; 2009 Dec; 39(12):1783-5. PubMed ID: 20085594
[No Abstract] [Full Text] [Related]
19. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
20. Mucosal dendritic cells in allergy and immunotherapy.
Novak N; Allam JP
Allergy; 2011 Jul; 66 Suppl 95():22-4. PubMed ID: 21668846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
